Hayato Hikita

Targets

• COX-2 1
• NRF2 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All-Cause Mortality After SVR in Advanced Chronic Hepatitis C.

  Hepatology research : the official journal of the Japan Society of Hepatology, Aug 2026

• Publication

  Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

  Hepatology research : the official journal of the Japan Society of Hepatology, Jul 2026

• Publication

  Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

  Hepatology research : the official journal of the Japan Society of Hepatology, May 2026

• Publication

  Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

  PloS one, May 2026

• Publication

  On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years.

  Journal of gastroenterology, Apr 2026

• Publication

  Impact of Treatment Response to Anticoagulant Therapy on Liver-Related Events in Patients With Cirrhosis and Portal Vein Thrombosis.

  Hepatology research : the official journal of the Japan Society of Hepatology, Mar 2026

• Publication

  Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

  Hepatology research : the official journal of the Japan Society of Hepatology, Feb 2026

• Publication

  Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients.

  Hepatology research : the official journal of the Japan Society of Hepatology, Jan 2026

• Publication

  Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage.

  PloS one, Jan 2026

• Publication

  NRF2-COX2-PGE 2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.

  Hepatology (Baltimore, Md.), Jan 2026

• Publication

  Growth differentiation factor 15: from stress response to clinical utility in chronic liver diseases.

  Journal of gastroenterology, Dec 2025

Affiliations

• The University of Osaka

Co-authors

• SESusumu EguchiHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.